|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, September 28, 2011 ) Belize City, Belize -- EAPH RESEARCH REPORT RELEASED THIS WEEKEND!
DirectglobalmediaÂ’s Research Report released this weekend, itÂ’s a must read for any investor:
http://www.xtremepicks.com/reports/eaph
Direct Global Media’s last report on DEGH rallied big time when they released their price target, jumping as much as 10,000% and exactly hitting their $0.75 target – when Direct Global Media puts out their report, people listen.
Easton Pharma - EAPH
John Mitchell worked with monster pharmaceutical companies including Bayer, Roche Diagnostics, and Eli Lilly – you bet he has some serious pull in getting products to market. This is a huge addition for EAPH management team.
With any tracebacks, it gives a solid opportunity to load up on the minor pull backs, a strategy xtremepicks.com always take advantage of to make some mega gains.
Long term plays build strength and establish solid support at these levels. Xtremepicks.com's monster 50,000% gainer DEGH has several minor pull backs on the way to huge gains. Strong and long term holders are the ones who reap the rewards.
EAPH Chart
Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition
Easton Pharmaceuticals, a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, announced today that John Mitchell has agreed to join the company as Vice President of Sales – North America. Mr. Mitchell brings years of pharmaceutical sales and marketing experience to compliment Easton Pharmaceuticals management team.
Mr. Mitchell has more than 30 years of sales and marketing experience, holding V.P. of Sales positions for several leading North American pharmaceutical and consumer products companies. Mitchell developed and implemented contract agreements for consumer promotions and OEM products for Bayer, Roche Diagnostics, Eli Lilly, Abbott, Medisense, and Lifescan, a division of J&J.
“We are extremely pleased to have a seasoned professional like John Mitchell join our team and lead our sales efforts,” stated John Easton, Easton Pharmaceuticals’ CEO and Chairman of the Board. “John will be a key member of our management team as Easton Pharmaceuticals opens new markets and distribution networks for our future product lines.”
As Vice President of Sales – North America, Mr. Mitchell will create and direct key sales and marketing programs, including direct to consumer and direct response marketing plans from product sourcing, packaging, label and product claim review, and full retail sales and marketing support. Mr Mitchell will be leveraging his extensive sales channel contacts to help Easton Pharmaceuticals build key retail bridges to all major U.S and Canadian retailers, include CVS, Walgreens, GNC, Wal-Mart plus many other retail outlets.
ABOUT EAPH – EASTON PHARMACEUTICALS
Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops and markets a range of premium, topically delivered therapeutic health care products. The companyÂ’s proprietary gel formulation is an innovative and unique transdermal delivery system.
The system is the technology that allows for the rapid development of non-invasive, naturally derived topical solutions that have the ability to revitalize and stimulate the healing of a variety of skin and tissue conditions. The transdermal delivery system allows for the targeted delivery of active ingredients, vitamins and herbs through the skin to the underlying tissue.
The company has utilized its transdermal delivery system to develop a safe and effective female sexual enhancement product. The companyÂ’s goal is to develop a portfolio of topical pharmaceutical and cosmeceutical products targeting various skin and tissue conditions including: scars and stretch marks, cellulite and varicose veins.
Xtremepicks.com your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.
Xtremepicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do your own due diligence. Xtremepicks receive $20K for a 2 week profile of EAPH from Direct Global Media and at times may buy EAPH in the open market. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved.
Directglobalmedia.com
Max Gordon
6479227508
contact@directglobalmedia.com 
Source: EmailWire.com
|
|
|
|
